Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $300000.0.

  • Bolt Biotherapeutics' Depreciation and Depletion fell 4000.0% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 5625.0%. This contributed to the annual value of $1.8 million for FY2024, which is 526.32% down from last year.
  • Per Bolt Biotherapeutics' latest filing, its Depreciation and Depletion stood at $300000.0 for Q3 2025, which was down 4000.0% from $300000.0 recorded in Q2 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Depreciation and Depletion peaked at $1.8 million during Q1 2024, and registered a low of $200000.0 during Q2 2021.
  • For the 5-year period, Bolt Biotherapeutics' Depreciation and Depletion averaged around $468421.1, with its median value being $400000.0 (2021).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first skyrocketed by 26000.0% in 2024, then plummeted by 7777.78% in 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Depreciation and Depletion (Quarter) stood at $400000.0 in 2021, then increased by 25.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then dropped by 20.0% to $400000.0 in 2024, then dropped by 25.0% to $300000.0 in 2025.
  • Its Depreciation and Depletion was $300000.0 in Q3 2025, compared to $300000.0 in Q2 2025 and $400000.0 in Q1 2025.